Follow
Gili Regev-Yochay
Gili Regev-Yochay
Associate Professor, Tel Aviv University
No verified email
Title
Cited by
Cited by
Year
Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months
EG Levin, Y Lustig, C Cohen, R Fluss, V Indenbaum, S Amit, R Doolman, ...
New England Journal of Medicine 385 (24), e84, 2021
15682021
Covid-19 breakthrough infections in vaccinated health care workers
M Bergwerk, T Gonen, Y Lustig, S Amit, M Lipsitch, C Cohen, ...
New England Journal of Medicine 385 (16), 1474-1484, 2021
14032021
Antibiotics in agriculture and the risk to human health: how worried should we be?
Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage
Evolutionary applications 8 (3), 240-247, 2015
6752015
Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection
I Nemet, L Kliker, Y Lustig, N Zuckerman, O Erster, C Cohen, Y Kreiss, ...
New England Journal of Medicine 386 (5), 492-494, 2022
4402022
Nasopharyngeal Carriage of Streptococcus pneumoniae by Adults and Children in Community and Family Settings
G Regev-Yochay, M Raz, R Dagan, N Porat, B Shainberg, E Pinco, ...
Clinical Infectious Diseases 38 (5), 632-639, 2004
3982004
Efficacy of a fourth dose of Covid-19 mRNA vaccine against Omicron
G Regev-Yochay, T Gonen, M Gilboa, M Mandelboim, V Indenbaum, ...
New England Journal of Medicine 386 (14), 1377-1380, 2022
3852022
Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children
G Regev-Yochay, R Dagan, M Raz, Y Carmeli, B Shainberg, E Derazne, ...
Jama 292 (6), 716-720, 2004
3852004
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
S Amit, G Regev-Yochay, A Afek, Y Kreiss, E Leshem
The Lancet 397 (10277), 875-877, 2021
3842021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers
Y Lustig, E Sapir, G Regev-Yochay, C Cohen, R Fluss, L Olmer, ...
The Lancet Respiratory Medicine 9 (9), 999-1009, 2021
3412021
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
M Lipsitch, F Krammer, G Regev-Yochay, Y Lustig, RD Balicer
Nature Reviews Immunology 22 (1), 57-65, 2022
2782022
Interference between Streptococcus pneumoniae and Staphylococcus aureus: In Vitro Hydrogen Peroxide-Mediated Killing by Streptococcus pneumoniae
G Regev-Yochay, K Trzcinski, CM Thompson, R Malley, M Lipsitch
Journal of bacteriology 188 (13), 4996-5001, 2006
2452006
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection
D Ben-David, Y Maor, N Keller, G Regev-Yochay, I Tal, D Shachar, ...
Infection Control & Hospital Epidemiology 31 (6), 620-626, 2010
2182010
Killing niche competitors by remote-control bacteriophage induction
L Selva, D Viana, G Regev-Yochay, K Trzcinski, JM Corpa, I Lasa, ...
Proceedings of the National Academy of Sciences 106 (4), 1234-1238, 2009
1962009
Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID‐19 vaccine
S Bookstein Peretz, N Regev, L Novick, M Nachshol, E Goffer, ...
Ultrasound in Obstetrics & Gynecology 58 (3), 450-456, 2021
1832021
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
S Sheikh-Mohamed, B Isho, GYC Chao, M Zuo, C Cohen, Y Lustig, ...
Mucosal immunology 15 (5), 799-808, 2022
1772022
Neutralising capacity against Delta (B. 1.617. 2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Y Lustig, N Zuckerman, I Nemet, N Atari, L Kliker, G Regev-Yochay, ...
Eurosurveillance 26 (26), 2100557, 2021
1762021
Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage
DM Weinberger, R Dagan, N Givon-Lavi, G Regev-Yochay, R Malley, ...
The Journal of infectious diseases 197 (11), 1511-1518, 2008
1732008
Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit
G Regev-Yochay, E Rubinstein, A Barzilai, Y Carmeli, J Kuint, J Etienne, ...
Emerging infectious diseases 11 (3), 453, 2005
1432005
SpxB Is a Suicide Gene of Streptococcus pneumoniae and Confers a Selective Advantage in an In Vivo Competitive Colonization Model
G Regev-Yochay, K Trzcinski, CM Thompson, M Lipsitch, R Malley
Journal of bacteriology 189 (18), 6532-6539, 2007
1332007
Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality
M Weinberger, L Leibovici, S Perez, Z Samra, I Ostfeld, I Levi, E Bash, ...
Journal of Hospital Infection 61 (2), 146-154, 2005
1282005
The system can't perform the operation now. Try again later.
Articles 1–20